🇯🇵 Loratinib in Japan

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Loratinib (Loratinib) regulatory status in Japan.

Marketing authorisation

PMDA

Application: Lorbrena
Local brand name: Lorbrena
Status: approved

Read official source →

Other Other approved in Japan

Frequently asked questions

Is Loratinib approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for Loratinib in Japan?

Guangdong Association of Clinical Trials is the originator. The local marketing authorisation holder may differ — check the official source linked above.